D-Wave (QBTS) Form 144: Proposed 144,000-Share Sale on NYSE
Rhea-AI Filing Summary
D-Wave Quantum (QBTS) Form 144: The filing notifies proposed sales of 144,000 common shares on the NYSE, scheduled approximately for 08/13/2025, with an aggregate market value of $2,603,602.21. Those shares represent a small fraction of the 338,605,149 shares outstanding and are listed in two lots: 119,000 shares (aggregate value $2,149,194.12) and 25,000 shares (aggregate value $454,408.09).
The filing also discloses how the shares were acquired: 119,000 shares were issued as grants on 04/01/2020 and 25,000 were an open market purchase on 11/17/2022 paid in cash. Separately, a sale by Steven M West of 311,973 shares on 05/21/2025 generated $5,148,802.39 in gross proceeds. The filer affirms no undisclosed material adverse information.
Positive
- Regulatory compliance: The filing provides detailed Rule 144 disclosure for proposed insider sales, including broker, quantities, and aggregate market values.
- Transaction transparency: Acquisition history is reported (grants on 04/01/2020 and open market purchase on 11/17/2022), and a recent insider sale on 05/21/2025 is disclosed with gross proceeds.
Negative
- Insider selling activity: A recent sale of 311,973 shares on 05/21/2025 produced $5,148,802.39 in gross proceeds, which some investors monitor as insider liquidity.
- Proposed sale size: The planned sale of 144,000 shares (approximate value $2,603,602.21) will increase available float, though it represents a small fraction of outstanding shares.
Insights
TL;DR Insider notice for modest proposed sales totaling $2.60M; prior insider sale of $5.15M disclosed.
The filing provides clear, transaction-level disclosure of proposed insider sales under Rule 144: 144,000 shares planned for sale on the NYSE on 08/13/2025, split into 119,000 shares from grants and 25,000 shares purchased in the open market. The filing also records a recent sale by Steven M West of 311,973 shares on 05/21/2025 for $5,148,802.39. Given the stated outstanding share count of 338,605,149, the proposed sale is a de minimis percentage of the float, and the document is primarily a compliance disclosure rather than new operational information.
TL;DR Routine insider liquidity disclosure; affirms representation of no undisclosed material information.
The Form 144 lists the nature and timing of acquisitions and the broker for execution, showing transparency in insider disposition. It documents that 119,000 shares stem from an issuer grant dated 04/01/2020 and 25,000 from an open market purchase on 11/17/2022. The filing includes a standard signed representation that the seller is not aware of undisclosed material adverse information. This is a standard governance disclosure supporting regulatory compliance rather than signaling corporate governance change.